EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.125, no.9, pp.634-637, 2017 (Journal Indexed in SCI)
Article / Article
Title of Journal :
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Objective Sclerostin is an osteocyte-secreted endogenous inhibitor of Wnt signaling. Several systemic and local factors have been suggested as possible regulators of sclerostin expression by osteocytes. In this study, we examined the effect of vitamin D treatment on sclerostin levels.